Delivery Order SPE2DB20D1100-SPE2DB24FC9G5
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a for-profit pharmaceutical distributor. The $2,850.12 contract is for the supply of 4565243575 ELIQUIS 2.5 MG TABLET 60S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,800.16 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564016271 ELIQUIS 2.5 MG TABLET 60S. This delivery order is a part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $3,074.77 delivery order contract to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs....
The U.S. Defense Logistics Agency (DLA) awarded a $9,388.10 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between DLA Troop Support Medical and Amerisourcebergen, which enables the agency to efficiently procure a comprehensive range of medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,900.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565177698 ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation. This order is for the supply of ELIQUIS 2.5 mg tablets and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,359.10 firm fixed price delivery order contract to provide ELIQUIS 5 MG TABLET 60S. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $7,807.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565767348 ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This $1,900.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of ELIQUIS 2.5 MG TABLET 60S. The award is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities to support military...